AZD1390 FOR RECURRENT GLIOBLASTOMA
  • March 15, 2022
A Phase 0/1b clinical trial to evaluate AZD1390 in patients with recurrent glioblastoma.
Read More
SONODYNAMIC THERAPY IN RECURRENT HIGH-GRADE GLIOMA
  • March 5, 2022
A Phase 0 research study of intravenous Aminolevulinic Acid Hydrochloride (ALA) and MR-guided focused ultrasound device (MRgFUS) in recurrent high-grade...
Read More
INFIGRATINIB FOR RECURRENT HIGH-GRADE GLIOMA
  • February 4, 2021
A Phase 0 study of infigratinib in recurrent high-grade glioma patients with an FGFR gene fusion scheduled for resection to...
Read More
RIBOCICLIB PLUS EVEROLIMUS FOR RECURRENT HIGH-GRADE GLIOMA
  • February 1, 2021
A Phase 0/2 study of ribociclib in combination with everolimus in preoperative Rb-intact recurrent high-grade glioma patients scheduled for resection
Read More